Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 31 av 31 resultater
Tid
Selskap
Tittel
Sektor
Kategori
24 Oct 2024
11:48 CEST
BONYF
PerioTabs Innovative 10-Day NitrAdine-Based Treatment to Revolutionize Oral Care
20103015 Pharmaceuticals
Products and services, Trends / Analyses
03 Sep 2024
00:52 CEST
BONYF
bonyf's Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks
20103015 Pharmaceuticals
Trends / Analyses
09 Aug 2024
18:15 CEST
BONYF
NitrAdine Dental Effervescent Tabs: Revolutionizing dental hygiene with unrivalled disinfecting power
20103015 Pharmaceuticals
Trends / Analyses
18 Jul 2024
09:19 CEST
BONYF
Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives
20103015 Pharmaceuticals
Trends / Analyses
28 Jun 2024
17:12 CEST
BONYF
bonyf NV: bonyf's 2023 financial statements made available
20103015 Pharmaceuticals
Commercial results
07 Jun 2024
17:13 CEST
BONYF
Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream
20103015 Pharmaceuticals
Trends / Analyses
10 May 2024
15:05 CEST
BONYF
2024 Sales Forecast: Unprecedented Growth on the Horizon
20103015 Pharmaceuticals
Commercial results
16 Apr 2024
15:19 CEST
BONYF
bonyf exhibits at PLMA Amsterdam on 28-29 May 2024
20103015 Pharmaceuticals
Sales, Other financial transaction
04 Apr 2024
18:17 CEST
BONYF
bonyf Advances to Phase 2 in Development of Alginate-Organic Denture Fixative Cream
20103015 Pharmaceuticals
Trends / Analyses, Products and services
13 Feb 2024
08:50 CET
BONYF
Bonyf R&D creates major breakthrough with 100% natural-origin ingredients new denture fixative cream
20103015 Pharmaceuticals
Other subject
11 Jan 2024
06:00 CET
BONYF
New Key Partnerships
20103015 Pharmaceuticals
Other subject
20 Jul 2023
18:00 CEST
BONYF
bonyf NV: bonyf’s 2022 financial statements made available
20103015 Pharmaceuticals
Other subject
30 Jun 2023
14:35 CEST
BONYF
bonyf NV: Delay in release of financial statements 2022
20103015 Pharmaceuticals
Other subject
14 Sep 2022
18:00 CEST
BONYF
bonyf NV : Hausse de 25% du chiffre d’affaires au S1 2022
20103015 Pharmaceuticals
Sales
14 Sep 2022
18:00 CEST
BONYF
bonyf NV: 25% increase in turnover in H1 2022
20103015 Pharmaceuticals
Sales
30 Jun 2022
19:00 CEST
BONYF
bonyf NV: ANNUAL RESULTS 2021
20103015 Pharmaceuticals
Income
30 Jun 2022
19:00 CEST
BONYF
bonyf NV: RESULTATS ANNUELS 2021
20103015 Pharmaceuticals
Income
15 Jun 2022
08:00 CEST
BONYF
bonyf NV: bonyf accelerates its export dynamics signing two new commercial contracts in Southeast Asia
20103015 Pharmaceuticals
News contracts
15 Jun 2022
08:00 CEST
BONYF
bonyf NV : Bonyf accélère sa dynamique à l’export avec la signature de deux nouveaux contrats commerciaux en Asie du Sud Est
20103015 Pharmaceuticals
News contracts
01 Jun 2022
18:00 CEST
BONYF
bonyf NV : Monsieur Ben Mettepenningen est nommé International Business Manager de bonyf
20103015 Pharmaceuticals
New
01 Jun 2022
18:00 CEST
BONYF
bonyf NV: bonyf appoints Ben Mettepenningen as International Business Manager
20103015 Pharmaceuticals
New
10 May 2022
08:00 CEST
BONYF
bonyf NV: BLEEDING WHILE BRUSHING TEETH IS A SIGN OF GUM DISEASE, A CONDITION LINKED TO THE DEVELOPMENT OF ALZHEIMER'S DISEASE
20103015 Pharmaceuticals
New
10 May 2022
08:00 CEST
BONYF
bonyf NV: UN SAIGNEMENT PENDANT LE BROSSAGE DES DENTS EST UN SIGNE DE MALADIE DES GENCIVES, UNE AFFECTION LIEE AU DEVELOPPEMENT DE LA MALADIE D'ALZHEIMER
20103015 Pharmaceuticals
New
06 Apr 2022
18:00 CEST
BONYF
Les crèmes fixatives pour prothèses dentaires à base de vaseline seraient-elles une cause d'inquiétude pour la santé ? bonyf apporte une solution alternative à cette nouvelle controverse
20103015 Pharmaceuticals
Trends / Analyses, Other subject
06 Apr 2022
18:00 CEST
BONYF
Are vaseline-based denture creams a cause for health concern? bonyf offers an alternative solution to this latest controversy
20103015 Pharmaceuticals
Trends / Analyses, Other subject
21 Mar 2022
08:00 CET
BONYF
bonyf NV: TO MARK WORLD ORAL HEALTH DAY, BONYF IS RAISING AWARENESS OF THE IMPORTANCE OF TEETH AND GUM HEALTH WITH ITS INNOVATIVE TECHNOLOGY
20103015 Pharmaceuticals
New
21 Mar 2022
08:00 CET
BONYF
bonyf NV: A L'OCCASION DE LA JOURNEE MONDIALE DE LA SANTE BUCCO-DENTAIRE, BONYF RAPPELLE LA NECESSITE DE PRESERVER DES GENCIVES ET DES DENTS SAINES
20103015 Pharmaceuticals
New
17 Mar 2022
08:45 CET
BONYF
bonyf NV: BONYF, L'EXPERT DU CONFORT BUCCO-DENTAIRE DE NOUVELLE GENERATION, ENTRE EN BOURSE AUJOURD'HUI
20103015 Pharmaceuticals
Share introduction and issues
17 Mar 2022
08:45 CET
BONYF
bonyf NV: BONYF, THE EXPERTS IN NEXT GENERATION ORAL AND DENTAL CARE GOES PUBLIC TODAY
20103015 Pharmaceuticals
Share introduction and issues
15 Mar 2022
10:28 CET
BONYF
bonyf NV : BONYF ANNONCE SON ENTREE EN BOURSE SUR EURONEXT PARIS
20103015 Pharmaceuticals
Share introduction and issues
15 Mar 2022
10:28 CET
BONYF
bonyf NV: BONYF ANNOUNCES LISTING ON PARIS EURONEXT
20103015 Pharmaceuticals
Share introduction and issues
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva